Free Trial

Nova (NVMI) Financials

Nova logo
$515.65 +23.36 (+4.75%)
Closing price 03:59 PM Eastern
Extended Trading
$516.26 +0.60 (+0.12%)
As of 04:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Nova

Annual Income Statements for Nova

This table shows Nova's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
16 9.64 46 54 35 48 93 140 136 184 259
Consolidated Net Income / (Loss)
16 9.64 46 54 35 48 93 140 136 184 259
Net Income / (Loss) Continuing Operations
16 9.64 46 54 35 48 93 140 136 184 259
Total Pre-Tax Income
12 11 60 63 39 56 109 158 155 216 303
Total Operating Income
12 10 58 60 36 56 112 150 132 188 253
Total Gross Profit
77 75 131 145 122 151 235 317 293 387 505
Total Revenue
149 164 222 251 225 269 416 571 518 672 881
Total Cost of Revenue
71 89 91 106 103 118 181 254 225 285 375
Total Operating Expenses
65 65 73 85 85 96 123 167 161 200 252
Selling, General & Admin Expense
8.51 6.84 8.10 8.74 10 13 17 24 20 24 26
Marketing Expense
16 22 25 28 28 30 40 53 52 65 82
Research & Development Expense
40 35 39 45 45 53 66 90 88 110 143
Total Other Income / (Expense), net
0.64 1.22 2.28 2.98 3.08 0.93 -3.13 8.48 22 29 50
Other Income / (Expense), net
- - - 2.98 3.08 0.93 -3.13 8.48 22 29 50
Income Tax Expense
-3.50 1.74 14 9.05 4.32 8.59 16 18 18 33 44
Basic Earnings per Share
$0.58 $0.35 $1.68 $1.94 $1.26 $1.71 $3.28 $4.89 $4.73 $6.31 $8.61
Weighted Average Basic Shares Outstanding
27.19M 27.17M 27.70M 28.02M 27.90M 28.10M 28.37M 28.70M 28.83M 29.11M 30.11M
Diluted Earnings per Share
$0.57 $0.35 $1.63 $1.89 $1.23 $1.65 $3.12 $4.43 $4.28 $5.75 $7.96
Weighted Average Diluted Shares Outstanding
27.51M 27.50M 28.52M 28.77M 28.57M 28.95M 29.82M 31.87M 32.09M 32.14M 32.80M

Quarterly Income Statements for Nova

No quarterly income statements for Nova are available.


Annual Cash Flow Statements for Nova

This table details how cash moves in and out of Nova's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
14 -7.33 7.29 -4.82 8.87 201 -106 -15 -4.15 50 57
Net Cash From Operating Activities
26 -4.16 62 37 41 60 132 120 124 235 246
Net Cash From Continuing Operating Activities
26 -4.16 62 37 41 60 132 120 124 235 246
Net Income / (Loss) Continuing Operations
16 9.64 46 54 35 48 93 140 136 184 259
Consolidated Net Income / (Loss)
16 9.64 46 54 35 48 93 140 136 184 259
Depreciation Expense
4.60 4.05 3.62 5.07 5.40 5.88 6.48 8.62 10 12 13
Amortization Expense
5.02 2.55 2.56 2.61 2.63 3.37 8.40 8.98 4.14 -0.26 5.15
Non-Cash Adjustments To Reconcile Net Income
2.66 2.96 2.78 5.34 4.58 6.72 11 25 23 32 11
Changes in Operating Assets and Liabilities, net
-2.22 -23 6.39 -30 -7.09 -3.62 13 -63 -50 8.12 -44
Net Cash From Investing Activities
-9.72 -4.38 -57 -37 -25 -42 -239 -100 -125 -136 -837
Net Cash From Continuing Investing Activities
-9.72 -4.38 -57 -37 -25 -42 -239 -100 -125 -136 -837
Purchase of Property, Plant & Equipment
-4.37 -3.13 -6.30 -3.68 -21 -6.44 -4.82 -21 -17 -17 -28
Acquisitions
-45 - - - - 0.00 0.00 -78 0.00 0.00 -56
Purchase of Investments
0.00 -1.25 -51 -33 0.00 0.00 -215 -212 -274 -272 -755
Sale and/or Maturity of Investments
40 0.00 0.00 0.00 0.00 0.00 13 81 195 246 305
Other Investing Activities, net
0.00 0.00 0.00 0.00 -4.18 -36 -31 130 -30 -94 -304
Net Cash From Financing Activities
-1.98 1.21 2.62 -4.44 -6.67 181 0.01 -30 0.01 -48 642
Net Cash From Continuing Financing Activities
-1.98 1.21 2.62 -4.44 -6.67 181 0.01 -30 0.01 -48 642
Repayment of Debt
- - - - - - - - 0.00 0.00 -20
Repurchase of Common Equity
-4.30 -0.94 0.00 -4.80 -7.16 -13 0.00 -21 -0.11 -30 -35
Issuance of Debt
- - - 0.00 0.00 194 0.00 0.00 0.00 -19 750
Other Financing Activities, net
2.32 2.15 2.62 0.36 0.49 0.37 0.01 -8.39 0.12 0.16 -53
Effect of Exchange Rate Changes
- - - -0.83 0.30 1.36 0.62 -4.45 -2.36 -0.32 6.35
Cash Income Taxes Paid
0.08 1.90 8.16 13 8.34 3.98 13 23 27 30 42

Quarterly Cash Flow Statements for Nova

No quarterly cash flow statements for Nova are available.


Annual Balance Sheets for Nova

This table presents Nova's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
207 219 283 333 400 656 805 984 1,134 1,390 2,361
Total Current Assets
150 168 232 282 303 559 567 613 710 902 1,411
Cash & Equivalents
28 20 28 23 32 232 127 111 108 158 214
Short-Term Investments
69 71 121 153 155 192 283 262 336 429 834
Accounts Receivable
19 43 41 54 52 63 68 109 111 139 152
Inventories, net
28 29 35 42 48 62 79 117 138 157 184
Other Current Assets
2.68 4.84 6.95 10 17 9.78 9.24 14 17 19 27
Plant, Property, & Equipment, net
11 10 14 14 31 34 34 56 67 82 103
Total Noncurrent Assets
46 41 37 38 67 59 199 314 356 398 846
Long-Term Investments
- - - 0.00 2.81 0.00 137 156 198 226 597
Goodwill
20 20 20 20 20 20 20 49 50 48 91
Intangible Assets
18 15 13 10 7.56 5.06 2.60 44 39 31 46
Noncurrent Deferred & Refundable Income Taxes
5.74 3.02 1.96 3.87 4.55 2.87 6.16 20 24 32 39
Other Noncurrent Operating Assets
0.21 0.23 0.36 0.53 29 30 31 46 45 61 73
Other Noncurrent Nonoperating Assets
2.26 2.18 2.25 3.39 3.21 1.48 1.60 0.00 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity
207 219 283 333 400 656 805 984 1,134 1,390 2,361
Total Liabilities
46 44 57 53 86 284 331 397 383 463 1,042
Total Current Liabilities
37 39 52 48 46 61 288 134 323 388 225
Short-Term Debt
- - - - - 0.00 183 0.00 198 181 0.00
Accounts Payable
14 17 16 19 21 24 36 43 35 60 47
Current Deferred Revenue
5.83 4.07 10 3.98 2.26 4.72 15 31 42 73 67
Other Current Liabilities
16 18 26 25 23 32 53 61 48 75 110
Total Noncurrent Liabilities
9.05 4.84 4.42 4.61 40 223 43 263 60 74 818
Long-Term Debt
- - - - 0.00 179 0.00 196 - 0.00 732
Noncurrent Deferred & Payable Income Tax Liabilities
5.76 1.09 0.00 - - - 0.00 12 11 8.50 10
Noncurrent Employee Benefit Liabilities
2.47 2.42 2.59 2.25 3.29 3.72 3.69 3.60 3.36 3.30 3.83
Other Noncurrent Operating Liabilities
0.82 1.33 1.83 2.36 36 41 40 51 46 63 72
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
161 175 227 281 315 372 474 587 751 928 1,318
Total Preferred & Common Equity
161 175 227 281 315 372 474 587 751 928 1,318
Total Common Equity
161 175 227 281 315 372 474 587 751 928 1,318
Common Stock
124 129 123 122 121 129 140 121 140 135 254
Retained Earnings
48 58 104 159 194 242 335 478 614 798 1,057
Accumulated Other Comprehensive Income / (Loss)
-0.11 -0.05 0.11 -0.19 0.02 0.57 -0.81 -13 -3.33 -5.30 6.55

Quarterly Balance Sheets for Nova

No quarterly balance sheets for Nova are available.


Annual Metrics And Ratios for Nova

This table displays calculated financial ratios and metrics derived from Nova's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
23.13% 10.36% 35.44% 13.13% -10.44% 19.78% 54.46% 37.16% -9.25% 29.83% 30.96%
EBITDA Growth
1.63% -20.95% 281.85% 11.11% -33.19% 38.37% 88.80% 41.80% -3.88% 34.63% 41.33%
EBIT Growth
-31.52% -12.22% 468.75% 9.70% -37.74% 43.08% 93.38% 44.99% -2.34% 39.81% 40.22%
NOPAT Growth
-17.47% -42.18% 418.94% 15.92% -37.42% 45.31% 103.24% 38.57% -12.18% 36.72% 35.96%
Net Income Growth
-15.69% -38.67% 381.74% 17.04% -35.32% 36.21% 94.34% 50.60% -2.78% 34.81% 41.06%
EPS Growth
-14.93% -38.60% 365.71% 15.95% -34.92% 34.15% 89.09% 41.99% -3.39% 34.35% 38.43%
Operating Cash Flow Growth
-23.12% -116.13% 1,585.84% -39.94% 9.61% 48.07% 119.51% -9.62% 3.34% 90.45% 4.40%
Free Cash Flow Firm Growth
-206.30% 60.73% 553.95% -49.51% -54.42% 311.41% 137.26% -115.57% 457.73% 179.99% -43.53%
Invested Capital Growth
237.16% 32.10% -7.59% 34.65% 20.41% -0.87% -15.31% 146.67% 20.89% -6.18% 40.40%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
51.90% 45.93% 59.10% 57.83% 54.16% 56.11% 56.58% 55.54% 56.61% 57.57% 57.37%
EBITDA Margin
14.28% 10.23% 28.83% 28.32% 21.13% 24.40% 29.83% 30.84% 32.67% 33.87% 36.56%
Operating Margin
7.80% 6.20% 26.05% 24.07% 16.19% 20.63% 27.01% 26.27% 25.54% 27.89% 28.78%
EBIT Margin
7.80% 6.20% 26.05% 25.26% 17.56% 20.97% 26.26% 27.76% 29.87% 32.17% 34.44%
Profit (Net Income) Margin
10.59% 5.88% 20.93% 21.65% 15.64% 17.78% 22.37% 24.57% 26.32% 27.33% 29.44%
Tax Burden Percent
128.64% 84.73% 77.31% 85.73% 89.07% 84.80% 85.22% 88.51% 88.11% 84.96% 85.47%
Interest Burden Percent
105.55% 111.96% 103.94% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
-28.64% 15.27% 22.69% 14.27% 10.93% 15.20% 14.78% 11.49% 11.89% 15.04% 14.53%
Return on Invested Capital (ROIC)
37.21% 12.02% 56.95% 58.58% 28.99% 38.72% 85.59% 74.61% 41.69% 53.73% 62.78%
ROIC Less NNEP Spread (ROIC-NNEP)
36.47% 10.95% 55.51% 57.03% 27.51% 38.36% 86.45% 72.48% 36.61% 49.23% 57.31%
Return on Net Nonoperating Assets (RNNOA)
-26.88% -6.27% -33.80% -37.15% -17.17% -24.75% -63.56% -48.17% -21.31% -31.84% -39.70%
Return on Equity (ROE)
10.32% 5.74% 23.15% 21.43% 11.82% 13.97% 22.03% 26.44% 20.38% 21.90% 23.08%
Cash Return on Invested Capital (CROIC)
-71.30% -15.64% 64.84% 29.05% 10.47% 39.59% 102.18% -10.01% 22.77% 60.11% 29.17%
Operating Return on Assets (OROA)
6.09% 4.77% 23.04% 20.57% 10.76% 10.70% 14.96% 17.71% 14.61% 17.14% 16.17%
Return on Assets (ROA)
8.26% 4.53% 18.51% 17.63% 9.59% 9.07% 12.75% 15.67% 12.87% 14.56% 13.82%
Return on Common Equity (ROCE)
10.32% 5.74% 23.15% 21.43% 11.82% 13.97% 22.03% 26.44% 20.38% 21.90% 23.08%
Return on Equity Simple (ROE_SIMPLE)
9.76% 5.52% 20.49% 19.37% 11.18% 12.89% 19.65% 23.89% 18.16% 19.81% 0.00%
Net Operating Profit after Tax (NOPAT)
15 8.61 45 52 32 47 96 133 117 159 217
NOPAT Margin
10.03% 5.26% 20.14% 20.63% 14.42% 17.49% 23.02% 23.25% 22.50% 23.70% 24.60%
Net Nonoperating Expense Percent (NNEP)
0.74% 1.07% 1.44% 1.55% 1.48% 0.35% -0.86% 2.13% 5.08% 4.50% 5.47%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 16.94% 12.29% 14.38% 10.57%
Cost of Revenue to Revenue
48.10% 54.07% 40.90% 42.17% 45.84% 43.89% 43.42% 44.46% 43.39% 42.43% 42.63%
SG&A Expenses to Revenue
5.73% 4.17% 3.65% 3.48% 4.48% 4.65% 4.16% 4.18% 3.94% 3.60% 2.97%
R&D to Revenue
26.73% 21.35% 17.55% 18.10% 19.79% 19.68% 15.83% 15.85% 17.00% 16.40% 16.28%
Operating Expenses to Revenue
44.10% 39.73% 33.05% 33.76% 37.98% 35.48% 29.57% 29.27% 31.07% 29.68% 28.59%
Earnings before Interest and Taxes (EBIT)
12 10 58 63 39 56 109 158 155 216 303
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
21 17 64 71 48 66 124 176 169 228 322
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.65 2.04 3.13 2.26 3.36 5.32 8.71 3.98 5.25 6.16 7.29
Price to Tangible Book Value (P/TBV)
2.16 2.56 3.66 2.54 3.68 5.71 9.15 4.72 5.96 6.74 8.14
Price to Revenue (P/Rev)
1.79 2.18 3.19 2.53 4.70 7.34 9.92 4.09 7.61 8.50 10.92
Price to Earnings (P/E)
16.91 36.97 15.25 11.69 30.03 41.27 44.34 16.65 28.91 31.10 37.09
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
5.91% 2.70% 6.56% 8.56% 3.33% 2.42% 2.26% 6.01% 3.46% 3.22% 2.70%
Enterprise Value to Invested Capital (EV/IC)
2.73 3.26 7.42 4.53 7.09 14.30 36.68 7.91 11.43 17.68 21.59
Enterprise Value to Revenue (EV/Rev)
1.14 1.62 2.52 1.83 3.86 6.43 9.04 3.51 6.75 7.55 9.88
Enterprise Value to EBITDA (EV/EBITDA)
7.97 15.85 8.74 6.46 18.25 26.35 30.32 11.37 20.67 22.28 27.03
Enterprise Value to EBIT (EV/EBIT)
14.59 26.13 9.68 7.25 21.96 30.66 34.45 12.64 22.60 23.46 28.69
Enterprise Value to NOPAT (EV/NOPAT)
11.34 30.84 12.52 8.87 26.74 36.76 39.30 15.08 30.00 31.85 40.16
Enterprise Value to Operating Cash Flow (EV/OCF)
6.55 0.00 9.05 12.38 21.31 28.75 28.45 16.75 28.30 21.57 35.42
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 11.00 17.89 74.03 35.95 32.92 0.00 54.92 28.47 86.44
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.48 0.39 0.33 0.26 0.19 0.56
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.48 0.00 0.33 0.00 0.00 0.56
Financial Leverage
-0.74 -0.57 -0.61 -0.65 -0.62 -0.65 -0.74 -0.66 -0.58 -0.65 -0.69
Leverage Ratio
1.25 1.27 1.25 1.22 1.23 1.54 1.73 1.69 1.58 1.50 1.67
Compound Leverage Factor
1.32 1.42 1.30 1.22 1.23 1.54 1.73 1.69 1.58 1.50 1.67
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 32.49% 27.87% 25.07% 20.84% 16.29% 35.69%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 27.87% 0.00% 20.84% 16.29% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 32.49% 0.00% 25.07% 0.00% 0.00% 35.69%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 67.51% 72.13% 74.93% 79.16% 83.71% 64.31%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 2.72 1.47 1.12 1.17 0.79 2.27
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 -3.73 -2.94 -1.89 -2.62 -2.81 -2.84
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 2.72 0.00 1.12 0.00 0.00 2.27
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 3.79 1.91 1.48 1.70 1.13 3.38
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 -5.20 -3.81 -2.51 -3.81 -4.01 -4.22
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 3.79 0.00 1.48 0.00 0.00 3.38
Altman Z-Score
5.33 6.85 10.25 10.12 9.71 6.30 9.44 5.90 8.25 9.66 7.56
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.04 4.30 4.45 5.86 6.55 9.17 1.97 4.57 2.20 2.32 6.28
Quick Ratio
3.12 3.42 3.65 4.77 5.15 8.00 1.66 3.60 1.72 1.87 5.35
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-29 -11 51 26 12 48 114 -18 64 178 101
Operating Cash Flow to CapEx
589.73% -132.78% 981.91% 1,009.35% 191.32% 935.17% 2,746.30% 560.85% 718.70% 1,366.63% 886.75%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.78 0.77 0.88 0.81 0.61 0.51 0.57 0.64 0.49 0.53 0.47
Accounts Receivable Turnover
8.58 5.32 5.31 5.32 4.28 4.69 6.32 6.42 4.70 5.37 6.05
Inventory Turnover
3.26 3.11 2.83 2.76 2.29 2.15 2.57 2.60 1.76 1.94 2.21
Fixed Asset Turnover
13.19 15.55 18.57 18.17 10.15 8.32 12.13 12.63 8.44 9.05 9.55
Accounts Payable Turnover
5.51 5.74 5.63 6.09 5.19 5.28 5.99 6.43 5.77 6.02 7.05
Days Sales Outstanding (DSO)
42.53 68.67 68.71 68.66 85.31 77.85 57.79 56.84 77.72 68.01 60.36
Days Inventory Outstanding (DIO)
111.87 117.26 128.99 132.19 159.59 169.94 141.82 140.43 206.90 188.57 165.43
Days Payable Outstanding (DPO)
66.29 63.59 64.83 59.92 70.32 69.16 60.92 56.78 63.25 60.60 51.81
Cash Conversion Cycle (CCC)
88.12 122.34 132.87 140.93 174.58 178.64 138.68 140.50 221.38 195.98 173.99
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
62 82 75 102 122 121 103 253 306 287 403
Invested Capital Turnover
3.71 2.29 2.83 2.84 2.01 2.21 3.72 3.21 1.85 2.27 2.55
Increase / (Decrease) in Invested Capital
43 20 -6.19 26 21 -1.06 -19 151 53 -19 116
Enterprise Value (EV)
169 266 560 460 867 1,732 3,763 2,002 3,497 5,075 8,701
Market Capitalization
266 357 709 636 1,056 1,977 4,128 2,334 3,940 5,714 9,615
Book Value per Share
$5.94 $6.45 $8.29 $10.06 $11.27 $13.27 $16.81 $20.54 $26.18 $31.98 $45.02
Tangible Book Value per Share
$4.53 $5.14 $7.09 $8.98 $10.28 $12.37 $16.01 $17.30 $23.07 $29.23 $40.36
Total Capital
161 175 227 281 315 550 657 783 948 1,108 2,050
Total Debt
0.00 0.00 0.00 0.00 0.00 179 183 196 198 181 732
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 179 0.00 196 0.00 0.00 732
Net Debt
-97 -91 -149 -176 -189 -245 -365 -333 -444 -640 -914
Capital Expenditures (CapEx)
4.37 3.13 6.30 3.68 21 6.44 4.82 21 17 17 28
Debt-free, Cash-free Net Working Capital (DFCFNWC)
16 38 31 58 70 74 51 105 141 108 138
Debt-free Net Working Capital (DFNWC)
113 129 180 233 257 498 462 479 585 694 1,186
Net Working Capital (NWC)
113 129 180 233 257 498 279 479 387 514 1,186
Net Nonoperating Expense (NNE)
-0.83 -1.03 -1.76 -2.56 -2.74 -0.79 2.67 -7.50 -20 -24 -43
Net Nonoperating Obligations (NNO)
-99 -93 -151 -179 -192 -250 -371 -334 -445 -641 -915
Total Depreciation and Amortization (D&A)
9.62 6.59 6.18 7.68 8.03 9.25 15 18 14 11 19
Debt-free, Cash-free Net Working Capital to Revenue
10.63% 23.00% 13.83% 22.96% 31.31% 27.43% 12.37% 18.46% 27.30% 16.02% 15.64%
Debt-free Net Working Capital to Revenue
75.97% 78.49% 80.99% 92.98% 114.13% 184.77% 110.94% 83.91% 112.97% 103.26% 134.71%
Net Working Capital to Revenue
75.97% 78.49% 80.99% 92.98% 114.13% 184.77% 66.95% 83.91% 74.80% 76.40% 134.71%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.58 $0.35 $1.68 $1.94 $1.26 $1.71 $3.28 $4.89 $4.73 $6.31 $8.61
Adjusted Weighted Average Basic Shares Outstanding
27.19M 27.18M 27.70M 28.02M 27.90M 28.10M 28.37M 28.70M 28.83M 29.11M 30.11M
Adjusted Diluted Earnings per Share
$0.57 $0.35 $1.63 $1.89 $1.23 $1.65 $3.12 $4.40 $4.28 $5.75 $7.96
Adjusted Weighted Average Diluted Shares Outstanding
27.51M 27.50M 28.52M 28.77M 28.57M 28.95M 29.82M 31.87M 32.09M 32.14M 32.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
27.09M 27.35M 27.90M 27.92M 28.01M 28.18M 28.58M 28.68M 29.01M 29.28M 0.00
Normalized Net Operating Profit after Tax (NOPAT)
8.11 8.61 45 52 32 47 96 133 117 159 217
Normalized NOPAT Margin
5.46% 5.26% 20.14% 20.63% 14.42% 17.49% 23.02% 23.25% 22.50% 23.70% 24.60%
Pre Tax Income Margin
8.23% 6.94% 27.07% 25.26% 17.56% 20.97% 26.26% 27.76% 29.87% 32.17% 34.44%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
27.36% 9.72% 0.00% 8.83% 20.35% 26.19% 0.00% 15.27% 0.08% 16.33% 13.50%

Quarterly Metrics And Ratios for Nova

No quarterly metrics and ratios for Nova are available.



Financials Breakdown Chart

Frequently Asked Questions About Nova's Financials

When does Nova's financial year end?

According to the most recent income statement we have on file, Nova's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has Nova's net income changed over the last 10 years?

Nova's net income appears to be on an upward trend, with a most recent value of $259.22 million in 2025, rising from $15.73 million in 2015. The previous period was $183.76 million in 2024. Check out Nova's forecast to explore projected trends and price targets.

What is Nova's operating income?
Nova's total operating income in 2025 was $253.47 million, based on the following breakdown:
  • Total Gross Profit: $505.20 million
  • Total Operating Expenses: $251.73 million
How has Nova's revenue changed over the last 10 years?

Over the last 10 years, Nova's total revenue changed from $148.51 million in 2015 to $880.58 million in 2025, a change of 492.9%.

How much debt does Nova have?

Nova's total liabilities were at $1.04 billion at the end of 2025, a 125.3% increase from 2024, and a 2,155.6% increase since 2015.

How much cash does Nova have?

In the past 10 years, Nova's cash and equivalents has ranged from $20.41 million in 2016 to $232.30 million in 2020, and is currently $214.46 million as of their latest financial filing in 2025.

How has Nova's book value per share changed over the last 10 years?

Over the last 10 years, Nova's book value per share changed from 5.94 in 2015 to 45.02 in 2025, a change of 658.6%.



Financial statements for NASDAQ:NVMI last updated on 2/22/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners